Spasmodic dysphonia: the need for a combined neurological and phoniatric approach
- PMID: 39718622
- PMCID: PMC11909014
- DOI: 10.1007/s00702-024-02868-x
Spasmodic dysphonia: the need for a combined neurological and phoniatric approach
Abstract
Spasmodic dysphonia (SD) is now generally considered to be a task-specific focal dystonia. For the first time, we wanted to explore the relationship between SD and dystonia from a combined neurological and phoniatric perspective. For this, we studied 115 patients with non-psychogenic SD by a combined neurological and phoniatric evaluation. Onset of SD was 49.7 ± 19.0 (6-68) years. The female/male ratio was 2. 63% had additional dystonia manifestations (cervical dystonia 35%, arm dystonia 15%, blepharospasm 11%, oromandibular dystonia 11%, writer's cramp 11%, pharyngeal dystonia 10%, generalised dystonia 4%, axial dystonia 2%, spasmodic dyspnoea 2% and segmental dystonia 1%). 71% occurred before, 25% after and 4% together with SD. 17% had a family history of dystonia and 6% a history of exposure to dopamine receptor blocking agents. 41% had mixed SD (SD-M), 31% abductor SD (SD-AB) and 28% adductor SD (SD-AD). SD-M was significantly correlated with additional dystonia manifestations and tremulous SD. No patient showed essential tremor or Parkinsonian syndromes. Two third of SD patients have additional dystonia manifestations and one fifth have a family history of dystonia, considerably more than previously described. In half of all patients, SD starts with non-SD dystonia. Our combined approach revealed a high prevalence of SD-M associated with frequent additional dystonia manifestations including dystonic tremor and a family history of dystonia. Patients presenting with SD should be evaluated for additional dystonia manifestations and dystonia patients should be evaluated for SD. Relevant coexistence of essential tremor and Parkinsonian syndromes cannot be confirmed.
Keywords: Abductor type; Adductor type; Dystonia; Essential tremor; Family history; Mixed type; Parkinsonian syndromes; Spasmodic dysphonia.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: DD received honoraria for services provided to Allergan, Ipsen, Merz, Lanzhou Institute of Biological Products, Medy-Tox, Revance, Desitin, Syntaxin, AbbVie, Medtronic, St Jude, Boston Scientific, Almirall, Bayer, Sun, Teva, UCB, WizMedi, IAB-Interdisciplinary Working Group for Movement Disorders. He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. FAS is founder and owner of IAB—Interdisciplinary Working Group for Movement Disorders. She received reimbursement from Abbot, AbbVie, Almirall, Allergan, Bayer, Desitin, Dynamed, Hempel GesundheitsPartner, Ipsen, Johnson & Johnson, Licher, Meda, Medtronic, Merz, Orion, PTZ Nawrath, Sensomotorik & Rehabilitation Hellmuth & Thiel, Sintetica, Sporlastic, Sun, Teva, Tricumed, TRS Med, UCB. LP and BK have nothing to disclose.
Similar articles
-
Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia.Acta Otorhinolaryngol Ital. 2020 Jun;40(3):198-203. doi: 10.14639/0392-100X-N0284. Acta Otorhinolaryngol Ital. 2020. PMID: 32773781 Free PMC article.
-
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset.Parkinsonism Relat Disord. 2020 Sep;78:129-133. doi: 10.1016/j.parkreldis.2020.07.026. Epub 2020 Aug 6. Parkinsonism Relat Disord. 2020. PMID: 32823241
-
The epidemiology of dystonia: the Hannover epidemiology study.J Neurol. 2022 Dec;269(12):6483-6493. doi: 10.1007/s00415-022-11310-9. Epub 2022 Aug 11. J Neurol. 2022. PMID: 35948800 Free PMC article.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
-
Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors.Otolaryngol Head Neck Surg. 2017 Oct;157(4):551-557. doi: 10.1177/0194599817728521. Epub 2017 Aug 29. Otolaryngol Head Neck Surg. 2017. PMID: 28850801 Review.
Cited by
-
Association of Laryngeal Dystonia With Common Neurologic Disorders.Laryngoscope. 2025 Jul 9:10.1002/lary.32407. doi: 10.1002/lary.32407. Online ahead of print. Laryngoscope. 2025. PMID: 40631777
References
-
- Aronson AE, Brown JR, Litin EM, Pearson JS (1968) Spastic dysphonia. I. Voice, neurologic, and psychiatric aspects. J Speech Hear Disord 33:203–218 - PubMed
-
- Blitzer A, Brin MF, Stewart CF (1998) Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 108:1435–1441 - PubMed
-
- Brodnitz FS (1976) Spastic dysphonia. Ann Otol Rhinol Laryngol 85:219–231 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources